How can we deal with COVID-19? With the shortages of some drugs, what can we do to improve the situation? by Hyun Ji (Angie) Chin | Apr 8, 2020 | Uncategorized
What is the purpose of DIR fees and what is their role in the healthcare system? If DIR fees are something we can’t avoid, what are some things we can do to improve transparency or allow for predictability when it comes to being charged DIR fees (formula in which they are calculated)? by Gloria Oh | Oct 3, 2019 | Uncategorized
How should the US deal with pharmaceutical pricing? by mchcaadm_admin | Jun 22, 2019 | UncategorizedReferences: Bipartisan bills aimed at lowering prescription drug prices Efforts to make prescription drugs more affordable
